Alzheimer's and Dementia


Publication Venue For

  • Genetic origin of a large family with a novel PSEN1 mutation (Ile416Thr) 2019
  • APOE-ε4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies..  14:1137-1147. 2018
  • Transethnic genome-wide scan identifies novel Alzheimer's disease loci.  13:727-738. 2017
  • Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses.  11:1439-1451. 2015
  • Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease.  10:349-359. 2014
  • Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development.  9:176-188. 2013
  • The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier).  9:189-198. 2013
  • Erratum: Estimating power with effect size versus slope differences: Both means and variance matter (Alzheimer's and Dementia (2011) 7 (247-249)).  7:556. 2011
  • Estimating power with effect size versus slop differences: Both means and variance matter.  7:247-249. 2011
  • Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials.  6:367-377. 2010
  • Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia.  4:421-427. 2008